Manufacturing GSK to quit Stevenage for new R&D site in Cambridge PharmaphorumIn a major shake-up of its UK operations, GSK is building a brand new R D centre in Cambridge and transfer operations there from its Stevenage campus.Read full story pharminent July 28, 2026 (Last updated: July 30, 2026) Pharmaphorum In a major shake-up of its UK operations, GSK is building a brand new R D centre in Cambridge and transfer operations there from its Stevenage campus. Read full story Post navigation Previous: Argenx signs agreement to buy Forte Biosciences for $2.2bnNext: Altimmune rises as GLP-1/GIP drug curbs heavy drinking in mid-stage study Related Stories Manufacturing BMS banks on Texas for $2.3bn multi-modal manufacturing facility pharminent August 11, 2026 Manufacturing AsymBio to secure $184m to support growth in biologics manufacturing pharminent August 5, 2026 Manufacturing Lilly and Resilience invest $750M in diabetes and obesity drug device supply pharminent July 31, 2026
